I join my colleagues on the Senate floor to discuss William Barr, President Trump's nominee to serve as America's next Attorney General. The Attorney General's job is to defend the U.S. Constitution against all enemies, foreign or domestic, and to stand up for the rights of all Americans, but President Trump has a different view of the Attorney General's role. He has made it quite clear that he is not interested in an Attorney General who is committed to working for the American people. For President Trump, only two criteria matter when it comes to picking an Attorney General. No. 1 is loyalty to President Trump. William Barr easily checks this box. Just look at the Mueller investigation. As Special Counsel Mueller's team investigates whether there are connections between Russia's meddling in the U.S. elections and the Trump campaign and indicts more and more people with close ties to the President, President Trump has viciously attacked the investigation, calling it a ``witch hunt.'' Trump was not pleased that his first pick for Attorney General, Jeff Sessions, recused himself from the Mueller investigation. He doesn't want to make the same mistake twice. In Barr, the President has found someone he believes will put the President's interests above those of the country, and it is not hard to see why.…
Share
More from Elizabeth Warren
Americans are now paying for it. Based on an analysis from the Congressional Budget Office and the Treasury Department’s own numbers, Trump’s tariffs cost families an average of $1,700.
I’m pretty outraged that you drag in billions of dollars from taxpayers and that you won’t submit to an audit when it’s clear that you have the opportunity to bilk the federal government and you have used that opportunity in other…
That is a clear conflict of interest. And yet, DOD actually requires the TRICARE pharmacy contractor to own both a PBM and a pharmacy. I don’t know who talked them into that, but it is an open invitation for Express Scripts to milk the…
Without greater visibility into these acquisitions, it is not just national security that could be on the line — Americans’ access to medicines is also at risk.





